Loading...
XASX
COH
Market cap13bUSD
Jul 11, Last price  
303.55AUD
1D
0.26%
1Q
21.14%
Jan 2017
147.69%
Name

Cochlear Ltd

Chart & Performance

D1W1MN
P/E
55.50
P/S
8.77
EPS
5.47
Div Yield, %
1.35%
Shrs. gr., 5y
2.63%
Rev. gr., 5y
9.62%
Revenues
2.26b
+15.47%
344,854,000452,260,000559,412,000601,725,000694,699,000734,803,000809,646,000778,996,000752,721,000804,936,000925,630,0001,130,552,0001,253,800,0001,363,700,0001,426,700,0001,352,300,0001,493,300,0001,641,100,0001,955,700,0002,258,200,000
Net income
357m
+18.70%
1,168,00080,032,000100,131,000115,234,000130,540,000155,152,000180,114,00056,803,000132,563,00093,709,000145,840,000188,921,000223,616,000245,800,000276,700,000-238,300,000326,500,000289,100,000300,600,000356,800,000
CFO
389m
+7.28%
98,634,00051,555,00076,836,00084,548,000146,628,000179,546,000201,277,000168,280,00069,727,000111,417,000188,701,000185,113,000259,800,000258,100,000296,000,000-157,800,000265,399,999376,500,000362,400,000388,800,000
Dividend
Sep 17, 20242.1 AUD/sh
Earnings
Aug 13, 2025

Profile

Cochlear Limited provides implantable hearing solutions for adults and children worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
URL
https://www.cochlear.com/sg/en/home
IPO date
Dec 04, 1995
Employees
4,800
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
2,258,200
15.47%
1,955,700
19.17%
Cost of revenue
1,736,700
1,543,300
Unusual Expense (Income)
NOPBT
521,500
412,400
NOPBT Margin
23.09%
21.09%
Operating Taxes
128,000
96,000
Tax Rate
24.54%
23.28%
NOPAT
393,500
316,400
Net income
356,800
18.70%
300,600
3.98%
Dividends
(245,700)
(197,400)
Dividend yield
1.13%
1.31%
Proceeds from repurchase of equity
(42,900)
(40,300)
BB yield
0.20%
0.27%
Debt
Debt current
41,600
39,200
Long-term debt
445,800
325,200
Deferred revenue
8,600
9,800
Other long-term liabilities
43,500
51,200
Net debt
(109,600)
(381,700)
Cash flow
Cash from operating activities
388,800
362,400
CAPEX
(62,400)
(95,900)
Cash from investing activities
(105,700)
(125,700)
Cash from financing activities
(323,800)
(310,400)
FCF
242,000
272,500
Balance
Cash
513,600
555,500
Long term investments
83,400
190,600
Excess cash
484,090
648,315
Stockholders' equity
1,840,500
1,748,800
Invested Capital
1,652,210
1,363,285
ROIC
26.10%
24.30%
ROCE
24.20%
20.32%
EV
Common stock shares outstanding
65,709
65,897
Price
332.15
45.00%
229.07
15.28%
Market cap
21,825,252
44.59%
15,094,992
15.51%
EV
21,715,652
14,713,292
EBITDA
521,500
493,300
EV/EBITDA
41.64
29.83
Interest
9,200
9,400
Interest/NOPBT
1.76%
2.28%